Cargando…

Gene mutation profiling in Chinese colorectal cancer patients and its association with clinicopathological characteristics and prognosis

BACKGROUND: Gene mutations may play an important role in the development, response to treatment and prognosis of colorectal cancer (CRC). This retrospective study aimed to investigate the mutation profiling of Chinese patients with CRC, and its correlation with clinicopathological features and progn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Zu‐Lu, Qiu, Miao‐Zhen, Tang, Tao, Wang, Fang, Zhou, Yi‐Xin, Lei, Meng‐Jie, Guan, Wen‐Long, He, Cai‐Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970031/ https://www.ncbi.nlm.nih.gov/pubmed/31782259 http://dx.doi.org/10.1002/cam4.2727

Ejemplares similares

Clinicopathologic Features and Prognosis of BRAF Mutated Colorectal Cancer Patients
por: Guan, Wen-Long, et al.
Publicado: (2020)

Clinicopathologic features and prognostic value of KRAS, NRAS and BRAF mutations and DNA mismatch repair status: A single‐center retrospective study of 1,834 Chinese patients with Stage I–IV colorectal cancer
por: Guo, Tian‐An, et al.
Publicado: (2019)

Up‐regulation of mir‐10b predicate advanced clinicopathological features and liver metastasis in colorectal cancer
por: Jiang, Hong, et al.
Publicado: (2016)

Clinicopathological Characteristics and Prognosis of Colorectal Cancer in Chinese Adolescent Patients
por: Du, Feng, et al.
Publicado: (2015)

Clinicopathological and mutational analyses of colorectal cancer with mutations in the POLE gene
por: Hino, Hitoshi, et al.
Publicado: (2019)

Clinicopathologic characteristics and outcomes of Chinese patients with non‐small‐cell lung cancer and BRAF mutation
por: Ding, Xi, et al.
Publicado: (2017)

HBV mutations in EnhII/BCP/PC region contribute to the prognosis of hepatocellular carcinoma
por: Ge, Zijun, et al.
Publicado: (2019)

POLE somatic mutations in advanced colorectal cancer
por: Guerra, Joana, et al.
Publicado: (2017)

First‐line therapy of bevacizumab plus chemotherapy versus cetuximab plus chemotherapy for metastatic colorectal cancer patients with mucinous adenocarcinoma or mucinous component
por: Zhou, Yu‐Wen, et al.
Publicado: (2021)

Clinicopathological characteristics of early onset colorectal cancer
por: Vuik, Fanny E. R., et al.
Publicado: (2021)

The genomic mutation spectrums of breast fibroadenomas in Chinese population by whole exome sequencing analysis
por: Xie, Shang‐Nao, et al.
Publicado: (2019)

Proteomic characteristics reveal the signatures and the risks of T1 colorectal cancer metastasis to lymph nodes
por: Zhuang, Aojia, et al.
Publicado: (2023)

High expression of DJ‐1 promotes growth and invasion via the PTEN‐AKT pathway and predicts a poor prognosis in colorectal cancer
por: Lin, Yong, et al.
Publicado: (2018)

The overexpression of AUF1 in colorectal cancer predicts a poor prognosis and promotes cancer progression by activating ERK and AKT pathways
por: Tian, Xin‐Yuan, et al.
Publicado: (2020)

SphK1‐driven autophagy potentiates focal adhesion paxillin‐mediated metastasis in colorectal cancer
por: Wu, Jiang‐Ni, et al.
Publicado: (2021)

Elevated expression of FREM1 in breast cancer indicates favorable prognosis and high‐level immune infiltration status
por: Li, Han‐ning, et al.
Publicado: (2020)

Systematic identification of mutations and copy number alterations associated with cancer patient prognosis
por: Smith, Joan C, et al.
Publicado: (2018)

Identification of novel mutations and functional impacts of EPAS1 in colorectal cancer
por: Islam, Farhadul, et al.
Publicado: (2021)

LncRNA NEAT1 knockdown attenuates autophagy to elevate 5‐FU sensitivity in colorectal cancer via targeting miR‐34a
por: Liu, Fen, et al.
Publicado: (2019)

Characteristics of cultured desmoid cells with different CTNNB1 mutation status
por: Hamada, Shunsuke, et al.
Publicado: (2015)

Detection of HPV infection in urothelial carcinoma using RNAscope: Clinicopathological characterization
por: Musangile, Fidele Y., et al.
Publicado: (2021)

Mismatch repair-signature mutations activate gene enhancers across human colorectal cancer epigenomes
por: Hung, Stevephen, et al.
Publicado: (2019)

The association between methylation patterns of DNAH17 and clinicopathological factors in hepatocellular carcinoma
por: Fan, Xiaoxiao, et al.
Publicado: (2018)

SNP mutation‐related genes in breast cancer for monitoring and prognosis of patients: A study based on the TCGA database
por: Gao, Chundi, et al.
Publicado: (2019)

Urokinase-type plasminogen activator receptor (uPAR) on tumor-associated macrophages is a marker of poor prognosis in colorectal cancer
por: Illemann, Martin, et al.
Publicado: (2014)

Copy number alterations in urothelial carcinomas: their clinicopathological significance and correlation with DNA methylation alterations
por: Nishiyama, Naotaka, et al.
Publicado: (2011)

Comprehensive genomic profiling of high‐grade serous ovarian carcinoma from Chinese patients identifies co‐occurring mutations in the Ras/Raf pathway with TP53
por: Zhong, Fangfang, et al.
Publicado: (2019)

Clinicopathological and prognostic significance of osteopontin expression in patients with prostate cancer: a systematic review and meta-analysis
por: Yu, Anze, et al.
Publicado: (2021)

Former smokers with non‐small‐cell lung cancers: a comprehensive investigation of clinicopathologic characteristics, oncogenic drivers, and prognosis
por: Zheng, Shanbo, et al.
Publicado: (2016)

Relationship of HER2 Alteration and Microsatellite Instability Status in Colorectal Adenocarcinoma
por: Qiu, Miao‐Zhen, et al.
Publicado: (2021)

The diagnostic accuracy of circulating free DNA for the detection of KRAS mutation status in colorectal cancer: A meta‐analysis
por: Xie, Wenli, et al.
Publicado: (2019)

Clinicopathological feature and prognosis of primary hepatic gastrointestinal stromal tumor
por: Liu, Zhen, et al.
Publicado: (2016)

Targeting posttranslational modifications of RIOK1 inhibits the progression of colorectal and gastric cancers
por: Hong, Xuehui, et al.
Publicado: (2018)

ARNT/HIF‐1β links high‐risk 1q21 gain and microenvironmental hypoxia to drug resistance and poor prognosis in multiple myeloma
por: Wu, Chuan, et al.
Publicado: (2018)

Clinicopathological features and lymph node and distant metastasis patterns in patients with gastroenteropancreatic mixed neuroendocrine‐non‐neuroendocrine neoplasm
por: Zhang, Panpan, et al.
Publicado: (2021)

Rpl24(Bst) mutation suppresses colorectal cancer by promoting eEF2 phosphorylation via eEF2K
por: Knight, John RP, et al.
Publicado: (2021)

A four‐gene signature associated with clinical features can better predict prognosis in prostate cancer
por: Yuan, Penghui, et al.
Publicado: (2020)

LncRNA DLX6-AS1 as a potential molecular biomarker in the clinicopathology and prognosis of various cancers: a meta-analysis
por: Tian, Shubo, et al.
Publicado: (2020)

Improving the overall survival prognosis prediction accuracy: A 9‐gene signature in CRC patients
por: Zheng, Wenbo, et al.
Publicado: (2021)

Optimization of routine KRAS mutation PCR-based testing procedure for rational individualized first-line-targeted therapy selection in metastatic colorectal cancer
por: Chretien, Anne-Sophie, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_h99lv1v9ui54fcrh06k91b4fa8